UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054398
Receipt number R000062136
Scientific Title Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study
Date of disclosure of the study information 2024/05/16
Last modified on 2024/05/14 22:10:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Acronym

Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Scientific Title

Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Scientific Title:Acronym

Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Region

Africa


Condition

Condition

Acne vulgaris and male sexual dysfunction

Classification by specialty

Dermatology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the presence of sexual dysfunction in male patients receiving isotretinion for treatment of acne vulgaris.

Assessment of the severity of acne.

Basic objectives2

Others

Basic objectives -Others

To evaluate relationship of male sexual dysfunction & symptoms of anxiety and depression in males caused by acne vulgaris and isotretinion treatment.
To evaluate the effect of isotretinion on male sexual desire

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To identify the presence of sexual dysfunction in male patients receiving isotretinion for treatment of acne vulgaris.
Assessment of the severity of acne.

Key secondary outcomes

To evaluate relationship of male sexual dysfunction & symptoms of anxiety and depression in males caused by acne vulgaris and isotretinion treatment.
To evaluate the effect of isotretinion on male sexual desire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group 1: normal males not receiving isotretinion (control group)

Interventions/Control_2

Group 2: male patient receiving isotretinion for 2 months.

Interventions/Control_3

Group 3: male patient receiving isotretinion for 4 months

Interventions/Control_4

Group 4: male patient receiving isotretinion for 6 months

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

45 years-old >=

Gender

Male

Key inclusion criteria

Males with severe nodulocystic acne

Key exclusion criteria

Any male with systemic illnesses or receiving medication causing erectile dysfunction or affecting his desire

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Sameh
Middle name Fayek
Last name GamalEl Din

Organization

Kasr Alainy faculty of medicine

Division name

Andrology & STDs

Zip code

002

Address

South academy, New cairo, Cairo

TEL

002025729584

Email

samehfayek@kasralainy.edu.eg


Public contact

Name of contact person

1st name Sameh
Middle name Fayek
Last name GamalEl Din

Organization

Cairo University

Division name

Andrology & STDs

Zip code

002

Address

South academy, New cairo, Cairo

TEL

002025729584

Homepage URL

http://scholar.cu.edu.eg/sfayek

Email

samehfayek@kasralainy.edu.eg


Sponsor or person

Institute

Cairo university

Institute

Department

Personal name

sameh fayek gamalEl Din


Funding Source

Organization

Cairo university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Beni Suef university

Address

Elsaray street elmanial

Tel

0020 25 729 584

Email

samehfayek@kasralainy.edu.eg


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 05 Month 12 Day

Date of IRB

2024 Year 05 Month 12 Day

Anticipated trial start date

2024 Year 05 Month 24 Day

Last follow-up date

2024 Year 05 Month 30 Day

Date of closure to data entry

2024 Year 12 Month 17 Day

Date trial data considered complete

2024 Year 12 Month 17 Day

Date analysis concluded

2024 Year 12 Month 17 Day


Other

Other related information



Management information

Registered date

2024 Year 05 Month 14 Day

Last modified on

2024 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062136